Tiziana Pressiani

机构：Humanitas University, IRCCS Humanitas Research Hospital · ORCID：0000-0001-6919-1536

发表论文 256 篇 · 总被引 8504 次 · h-index 38

代表论文

• Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcome (2025 · Gut · 被引 13)
• Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study (2025 · JHEP Reports · 被引 12)
• Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers (2025 · Liver International · 被引 10)
• Molecular profiling and matched targeted treatment in cholangiocarcinoma: Results from the Italian dataset (ANITA) (2025 · Journal of Hepatology · 被引 6)
• Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab (2025 · Liver International · 被引 6)
• Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study (2025 · Liver Cancer · 被引 5)